Share
Save
National Prisons Hepatitis Education Project: Research Evaluation
The National Prisons Hepatitis Education Program (HepPEd Program) is a national, prison-based hepatitis C health literacy education program for healthcare providers, correctional officers, and people in prison. The HepPEd Program aims to improve the public health literacy of the prison sector regarding hepatitis C in prisons. The HepPEd: Research Evaluation aims to evaluate the impact of the HepPEd Program on HCV testing and treatment uptake amongst people incarcerated in Australian prisons, as well as changes in knowledge, attitudes, and capabilities of healthcare providers, correctional officers, and people in prison.
The study is a controlled before and after study being conducted in 3-6 correctional centres in Australia.
Study details:
The National Prisons Hepatitis Education Program (HepPEd Program) is a national, prison-based hepatitis C health literacy education program for healthcare providers, correctional officers, and people in prison. The broad goal of HepPEd: Research Evaluation is to measure the impact of a prison-specific hepatitis C (HCV) education program (the HepPEd Program) on enhancing HCV testing and treatment rates in Australian prisons. The HepPEd Program aims to improve HCV testing and treatment rates by enhancing the public health literacy of the prison sector regarding HCV in the prisons (that is the knowledge, attitudes and behaviours), and specifically targets the three key audience groups from the prison setting: healthcare providers, correctional officers, and people in prison.
The study will be conducted as a prison-level, controlled before-and-after trial with a primary objective of evaluating the impact of the HepPEd Program on HCV treatment uptake amongst people incarcerated in Australian prisons. Three to six Australian correctional centres will be selected to participate in the 9-month study. Each correctional centre will have a 3-month period of pre-intervention surveillance, involving monthly observation of HCV treatment uptake under existing operations.
This will be followed by a three-month period of education delivery of the HepPEd Program (the 'education intervention'). The monthly surveillance data collection will continue during the intervention period. Finally, each correctional centre will have another 3-month period of post-intervention surveillance, again involving monthly surveillance of HCV treatment rates.
Surveys will be conducted with members from each target audience group before and after the education intervention and dried blood spot testing will be conducted with members from the people in prison group to assess baseline HCV prevalence before the education intervention.
Eligibility criteria
Researchers look for people who fit a certain description, called eligibility criteria. See if you qualify.
Inclusion criteria
Eligibility
Age eligible for study : 18 and older
Healthy volunteers accepted : Yes
Gender eligible for study: All
Things to know
Study dates
Study start: 2023-09-04
Primary completion: 2024-07-01
Study completion finish: 2024-12-01
Study type
OTHER
Phase
NA
Trial ID
NCT05942937
Intervention or treatment
OTHER: Education Intervention (The HepPEd Program)
Conditions
- • HCV
Find a site
Closest Location:
Capricornia Correctional Centre
Research sites nearby
Select from list below to view details:
Capricornia Correctional Centre
Rockhampton, Queensland, Australia
Risdon Prison Complex
Hobart, Tasmania, Australia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Participant Group/Arm | Intervention/Treatment |
---|---|
EXPERIMENTAL: Whole-of-prison education intervention
| OTHER: Education Intervention (The HepPEd Program)
|
What is the study measuring?
Primary outcome
Primary Outcome Measure | Primary Outcome Description | Primary Outcome Time Frame |
---|---|---|
The change in the proportion of prisoners treated for HCV before and after the education intervention. | This will be measured by calculating the change in HCV treatment rates before and after the education intervention. | 9 months from baseline |
Secondary outcome
Secondary Outcome Measure | Secondary Outcome Description | Secondary Outcome Time Frame |
---|---|---|
The proportion of prisoners tested for HCV before and after the education intervention. | This will be measured by calculating the change in HCV testing rates before and after the education intervention. | 9 months from baseline |
The health literacy (knowledge, attitudes, and capabilities) amongst target audience groups (healthcare providers, correctional officers, and people in prison) before and after the education intervention. | This will be measured by assessing the change in health literacy before and after the education intervention. | 9 months from baseline |
The acceptability, utility, and impact of the HepPEd Program. | This is measured by surveys, before and after the education intervention. | 9 months from baseline |
The dose, reach, and fidelity of the HepPEd Program. | This is measured by surveys, before and after the education intervention. | 9 months from baseline |
Frequently Asked Questions
Please note: some questions and answers are submitted by anonymous patients or using AI, and have not been verified by Clinrol
No questions submitted. Be the first to ask a question!